NASDAQ : CMPS
COMPASS Pathways plc — Key statistics
Healthcare · Medical Care Facilities · United Kingdom
Last price 12.19 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 1.69B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 1.56B |
| Enterprise Value | 1.18B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 3, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | n/a |
| Shares Outstanding | 138.48M |
| Shares Change (YoY) | +36.55% |
| Shares Change (QoQ) | +22.41% |
| Owned by Insiders (%) | 1.64% |
| Owned by Institutions (%) | 50.63% |
| Float | 106.97M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 613.91 |
| PB Ratio | 18.58 |
| P/TBV Ratio | 18.67 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.30 |
| Quick Ratio | 1.22 |
| Debt / Equity | 0.65 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -35.78 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -319.07% |
| Return on Assets (ROA) | -29.08% |
| Return on Invested Capital (ROIC) | -68.88% |
| Return on Capital Employed (ROCE) | -135.27% |
| Weighted Average Cost of Capital (WACC) | 17.99% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.53M |
| Employee Count | 156 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | -2.64M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 2.56 |
| 52-Week Price Change | +80.38% |
| 50-Day Moving Average | 12.87 |
| 200-Day Moving Average | 10.42 |
| Relative Strength Index (RSI) | 44.08 |
| Average Volume (20 Days) | 2,179,710 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 17.67M |
| Short Previous Month | 17.03M |
| Short % of Shares Out | 12.93% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 6.40 |
Incomestatement
| Measure | Value |
|---|
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -185.69M |
| Pretax Income | -396.83M |
| Net Income | -394.19M |
| EBITDA | -185.56M |
| EBIT | -185.69M |
| Earnings Per Share (EPS) | -$3.61 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 433.30M |
| Total Debt | 54.63M |
| Net Cash | 378.67M |
| Net Cash Per Share | $2.73 |
| Equity (Book Value) | 84.53M |
| Book Value Per Share | 0.62 |
| Working Capital | 108.39M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -161.14M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 129,000 |
| Net Borrowing | 18.58M |
| Free Cash Flow | -161.14M |
| FCF Per Share | -$1.16 |
Margins
| Measure | Value |
|---|
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -36.55% |
| Shareholder Yield | -36.55% |
| Earnings Yield | -31.97% |
| FCF Yield | -10.21% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $23.75 |
| Price Target Difference | 110.36% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 16 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |